Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Addiction and ADHD

New digital paths in the therapy of comorbid diseases

    • Congress Reports
    • Neurology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
  • 4 minute read

The digital transformation is in full swing. Intensive research is being conducted into new applications for virtual reality. Psychiatry in particular could benefit from the new technology. Addictive disorders and ADHD, which is often comorbid, present with limited diagnostic and therapeutic options. Can new, digital paths be taken here?

Virtual lifestyles are becoming increasingly important. Computer-based immersion and virtual presence have long since left the pure game world. Science, too, is increasingly making use of this world of experience. Virtual reality (VR) can be used to investigate self- and body perception, social situations, and the experience of spaces or contexts. Kornelius Kammler-Sücker, Mannheim (D), pointed out that the possibilities are manifold. In this way, experiments can be standardized, motivation can be increased with the help of the game character, imagination techniques can be applied in a protected setting, and impossible situations can be made possible. In the future, the digitalization of society will lead to people moving more and more into virtual living environments. However, this can also pose dangers, especially in the psychiatric context. After all, the digitally generated environment must not be a substitute for the real physical-social living environment. Moreover, science is still in its infancy in this regard, so results are often not easy to interpret. Critical interdisciplinarity is needed here to exploit the advantages of the new treatment pathways without giving room to the disadvantages. But it is worth it, the expert is sure.

Addiction treatment interdisciplinary

Tobacco use is undoubtedly one of the most common addictions. It causes the deaths of eight million people worldwide every year. Even after smoking cessation, sustained abstinence is rare. In other words, the recidivism rate is high. However, therapeutic measures to increase abstinence rates are severely limited. This is because the psychological and biological mechanisms underlying smoking behavior in the context of divergent environmental factors are not yet well understood. Study results suggest that smokers are more likely to reach for a cigarette when they are in the presence of others who smoke. Non-smoking attendants, on the other hand, reduce the likelihood of smoking. Implicit craving for a cigarette, approach behavior to and an attentional bias toward cigarette stimuli, as well as explicit craving and hormonal processes might mediate these associations, stated Katharina Eidenmüller, Mannheim (D).

Specifically, possible mediators include hypersensitization to motivational incentive effects. The increased wanting of the substance is due to changes in motivationally relevant dopamine systems. In addition, attentional bias also plays a role. Automatic selective attentional bias toward substance-associated stimuli is an important predictor of the outcome of targeted smoking abstinence. Approach bias represents the third aspect. It defines the automatic approach tendency toward substance-associated stimuli and is measurable with the Approach Avoidance Task. In addition, especially in the context of stress and social interactions, relevant hormones exist that serve as mediators between environmental factors and behavior. These include, for example, cortisol, arginine vasopressin and oxytocin.

What can VR do that normal life can’t?

There are tools to examine all of these mediators. Why would VR come into play? One reason is the high ecological validity with simultaneous high standardizability, according to the expert. Moreover, craving for cigarettes can be generated in the simulation and does not have to be completed in real life. This is because the VR environment with smoking cues generates thoughts and smoking and heightened attention to cigarette-associated stimuli. For example, it was found that interactions with smoking avatars in VR rooms elicited stronger craving than in smoking cues without avatars. A recently launched study is looking into this in more detail. Under investigation are the hypotheses that the presence of a smoking avatar triggers more implicit wanting for cigarettes, a stronger approach tendency to cigarette stimuli, a stronger attentional bias, and a stronger craving for a cigarette in smokers. After smoking a cigarette, these same mediators are expected to decrease. Similarly, arginine vasopression is expected to decrease, whereas cortisol and oxytocin increase.

Help with diagnostics and therapy of adult ADHD

Virtual reality can also assist in the diagnostic and treatment management of adult ADHD. Because although ADHD is defined by inattention, hyperactivity, and impulsivity, these symptoms often cannot be detected or treated by common neuropsychological methods, explained Niclas Braun, MD, Bonn (D). The reason for this paradox is probably the low ecological validity of currently existing neuropsychological procedures. VR makes it possible to create a realistic and symptom-relevant testing environment that remains highly standardizable at the same time. Inspired by virtual classroom environments for children with ADHD, a virtual seminar room environment for adults with ADHD, among others, can be used for a multimodal characterization of inattention and impulsivity. In a feasibility study with 26 healthy subjects, test performance, experience sampling, EEG theta-beta ratios, EEG P300 amplitudes, and head movements/rotations, among others, were examined. Subjects performed a Continuous Performance Task directly in the virtual seminar room while various distracting events were played simultaneously. It was shown that simultaneous study of behavioral performance, EEG, and actigraphy in VR is possible. In addition, the healthy controls tolerated this setup well and were compliant. In a next step, the test of the paradigm must now be performed on patients with ADHD.

Source: “Virtual reality technologies in addiction and ADHD therapy (research),” 11/27/2021.
Congress: dgppn 2021

 

 

InFo NEUROLOGY & PSYCHIATRY 2022; 20(1): 30-31.

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • adult ADHD
  • Virtual Reality
  • VR
Previous Article
  • Diroximelfumarate (VumerityTM) in relapsing-remitting multiple sclerosis

Current analysis confirms favorable benefit-risk profile

  • Neurology
  • RX
View Post
Next Article
  • From symptom to diagnosis

Pain and swelling of the wrist radial – Tendovaginitis stenosans de Quervain

  • Cases
  • Education
  • General Internal Medicine
  • Orthopedics
  • Radiology
  • RX
View Post
You May Also Like
View Post
  • 17 min
  • Sleep-wake disorders in pneumology practice

Patience, knowledge and persistence in therapy

    • CME continuing education
    • General Internal Medicine
    • Neurology
    • Pneumology
    • RX
View Post
  • 9 min
  • Chronic lung diseases

Sarcopenia and malnutrition in the context of pneumological rehabilitation

    • CME continuing education
    • General Internal Medicine
    • Geriatrics
    • Nutrition
    • Pneumology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 19 min
  • Cardiovascular risk and obesity

Pathomechanisms, secondary prevention and treatment options

    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • Nutrition
    • RX
    • Sports Medicine
    • Studies
    • Training with partner
View Post
  • 9 min
  • Oxidative stress and neurodegeneration

Insights and therapeutic strategies for Parkinson’s disease

    • Education
    • Neurology
    • Phytotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Biologics for atopic dermatitis

Th2 cytokines in focus: proven and new targets

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 3 min
  • Teens, Screen and Mental Health

How social media influences depression in young people

    • Education
    • Pediatrics
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
View Post
  • 4 min
  • CHD: Management after revascularization

Individualization of antithrombotic therapy

    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 30 min
  • Chemsex - MSM, sex, chrystal meth & co.

Medical and psychosocial perspectives

    • CME continuing education
    • General Internal Medicine
    • Infectiology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.